Figure 3. Distribution of indication classes in predicted novel usages.
Each indication for the 403 high confidence novel usages with support in FAERS and MEDLINE was mapped to the first level of the NDF-RT disease hierarchy. 63 usages were not mapped to NDF-RT and were left out of this chart.